Thompson Davis & Co., Inc. Chemo Centryx, Inc. Transaction History

Thompson Davis & Co., Inc.

$112 Million
Q2 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 03, 2018	SELL	$10.62 - $13.98 $6,637 - $8,737	-625 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$5.9 - $14.99 $3,687 - $9,368	625 New	625 $9,000
Q3 2017 Oct 30, 2017	SELL	$6.5 - $10.69 $3,250 - $5,345	-500 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	500	500 $5,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.